Clincosm LogoSign in Get a demo

malignant melanoma stage iii

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma Stage III Trial in Worldwide (Ipilimumab, Nivolumab, Surgery)

Active, not recruiting
  • Malignant Melanoma Stage III
  • Sydney, New South Wales, Australia
  • +3 more
Apr 14, 2022

Malignant Melanoma Stage III Trial in Australia, Netherlands, United States (Neoadjuvant ipilimumab + nivolumab, Adjuvant

Recruiting
  • Malignant Melanoma Stage III
  • Neoadjuvant ipilimumab + nivolumab
  • Adjuvant nivolumab
  • Houston, Texas
  • +18 more
Aug 18, 2021

Malignant Melanoma Stage III, Malignant Melanoma Stage IV Trial in Jette (TriMix-DC and ipilimumab)

Completed
  • Malignant Melanoma Stage III
  • Malignant Melanoma Stage IV
  • TriMix-DC and ipilimumab
  • Jette, Brabant, Belgium
    UZ Brussel
Mar 24, 2021

Malignant Melanoma Stage IV, Malignant Melanoma Stage III Trial (quantification of BRAF and NRAS mutation)

Unknown status
  • Malignant Melanoma Stage IV
  • Malignant Melanoma Stage III
  • quantification of BRAF and NRAS mutation
  • (no location specified)
Apr 11, 2018

Malignant Melanoma Stage III, Malignant Melanoma Stage IV Trial in Brussel (Dendritic cell therapy)

Completed
  • Malignant Melanoma Stage III
  • Malignant Melanoma Stage IV
  • Dendritic cell therapy
  • Brussel, Belgium
    UZ Brussel
May 23, 2017

Malignant Melanoma Stage III, Malignant Melanoma Stage IV Trial in Dallas (IL15-DC Vaccine)

Completed
  • Malignant Melanoma Stage III
  • Malignant Melanoma Stage IV
  • IL15-DC Vaccine
  • Dallas, Texas
    Baylor University Medical Center
Dec 20, 2016